Sleimann Madelaine, Balcerek Magdalena, Cytera Chirine, Richter Franziska, Borgmann-Staudt Anja, Wörmann Bernhard, Kronziel Lea Louisa, Calaminus Gabriele, Kock-Schoppenhauer Ann-Kristin, Grabow Desiree, Baust Katja, Neumann Anke, Langer Thorsten, Gebauer Judith
Medizinische Klinik 1, Abteilung für Endokrinologie, Diabetologie und Stoffwechselmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Department of Paediatric Oncology and Haematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Campus Virchow-Klinikum, Augustenburger Platz 1, Mittelallee 6A, 13353, Berlin, Germany.
J Cancer Res Clin Oncol. 2023 Nov;149(14):12855-12866. doi: 10.1007/s00432-023-05145-8. Epub 2023 Jul 18.
Childhood cancer survivors (CCS) are at risk for increased morbidity and reduced quality of life associated with treatment-related late effects. In Germany, however, only a few of the more than 40,000 CCS registered in the German Childhood Cancer Registry (GCCR) currently benefit from adequate clinical long-term follow-up (LTFU) structures. To establish a comprehensive knowledge base on CCS' long-term health in Germany, a database was developed in cooperation with the GCCR. Following a first evaluation phase at two German university centres, this database will be implemented more widely within Germany allowing longitudinal documentation of clinical LTFU data.
The feasibility study cohort comprised 208 CCS aged 18 or older whose medical, mental and psychosocial health data were collected during routine LTFU or first clinic visits in adult care. CCS were enrolled from 04/2021 to 12/2022, and data entry was completed by 03/2023. Descriptive data analysis was conducted. All CCS were stratified into three risk groups (RG) based on their individual risk for developing late effects resulting from their respective diagnoses and treatments.
Chronic health conditions of various organ systems associated with late and long-term effects of cancer therapy affected CCS in all RG supporting the clinical relevance of risk-adapted LTFU. Enrolment into the database was feasible and broadly accepted amongst CCS.
Implementation of a clinical follow-up care infrastructure and database in Germany will pave the way to collect clinically evaluated and regularly updated health data of potentially over 40,000 German CCS and facilitate future national and international cooperation.
儿童癌症幸存者(CCS)面临与治疗相关的晚期效应导致发病率增加和生活质量下降的风险。然而,在德国,在德国儿童癌症登记处(GCCR)登记的40000多名CCS中,目前只有少数人受益于充分的临床长期随访(LTFU)结构。为了建立关于德国CCS长期健康的全面知识库,与GCCR合作开发了一个数据库。在德国两个大学中心进行了第一阶段评估后,该数据库将在德国更广泛地实施,以便对临床LTFU数据进行纵向记录。
可行性研究队列包括208名18岁及以上的CCS,他们的医疗、心理和社会心理健康数据在常规LTFU或成人护理首次门诊就诊期间收集。CCS于2021年4月至2022年12月入组,数据录入于2023年3月完成。进行了描述性数据分析。所有CCS根据其各自诊断和治疗产生晚期效应的个体风险分为三个风险组(RG)。
与癌症治疗的晚期和长期效应相关的各种器官系统的慢性健康状况影响了所有RG中的CCS,支持了风险适应性LTFU的临床相关性。将CCS纳入数据库是可行的,并且在CCS中得到了广泛接受。
在德国实施临床随访护理基础设施和数据库将为收集潜在的40000多名德国CCS的临床评估和定期更新的健康数据铺平道路,并促进未来的国内和国际合作。